HSP90AB2P expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.802600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.508800E-01
Normal-vs-Stage2
8.209400E-01
Normal-vs-Stage3
4.372800E-01
Normal-vs-Stage4
5.306000E-01
Stage1-vs-Stage2
2.888400E-01
Stage1-vs-Stage3
2.835200E-01
Stage1-vs-Stage4
4.856600E-01
Stage2-vs-Stage3
4.095200E-01
Stage2-vs-Stage4
4.353600E-01
Stage3-vs-Stage4
3.447600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.241400E-01
Normal-vs-AfricanAmerican
9.696400E-01
Normal-vs-Asian
4.709800E-01
Caucasian-vs-AfricanAmerican
9.449600E-01
Caucasian-vs-Asian
1.821010E-01
AfricanAmerican-vs-Asian
3.691200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.570000E-01
Normal-vs-Female
9.079000E-01
Male-vs-Female
9.043000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.703000E-01
Normal-vs-Age(41-60Yrs)
7.981600E-01
Normal-vs-Age(61-80Yrs)
6.531000E-01
Normal-vs-Age(81-100Yrs)
7.712400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.199300E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.335600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.311000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.219600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.664600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.044200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.193000E-01
Normal-vs-Daily Drinker
5.847200E-01
Normal-vs-Weekly Drinker
8.749200E-01
Normal-vs-Occasional Drinker
9.723200E-01
Normal-vs-Social Drinker
9.579600E-01
Non Drinker-vs-Daily Drinker
4.853800E-01
Non Drinker-vs-Weekly Drinker
8.498200E-01
Non Drinker-vs-Occasional Drinker
6.960000E-01
Non Drinker-vs-Social Drinker
7.552400E-01
Daily Drinker-vs-Weekly Drinker
4.119200E-01
Daily Drinker-vs-Occasional Drinker
3.241200E-01
Daily Drinker-vs-Social Drinker
3.901000E-01
Weekly Drinker-vs-Occasional Drinker
8.521400E-01
Weekly Drinker-vs-Social Drinker
8.979600E-01
Occasional Drinker-vs-Social Drinker
9.675800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.212800E-01
Normal-vs-Grade 2
2.483000E-01
Normal-vs-Grade 3
3.196400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.035800E-01
Grade 1-vs-Grade 3
3.772800E-01
Grade 1-vs-Grade 4
2.212800E-01
Grade 2-vs-Grade 3
6.187600E-01
Grade 2-vs-Grade 4
2.483000E-01
Grade 3-vs-Grade 4
3.196400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.368000E-01
Normal-vs-NonDiabetic
7.559200E-01
Diabetic-vs-NonDiabetic
6.521400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.336000E-01
Normal-vs-NoPancreatitis
7.198800E-01
Pancreatitis-vs-NoPancreatitis
2.483800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.434000E-01
Normal-vs-N1
7.840000E-01
N0-vs-N1
3.283200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.921800E-01
Normal-vs-TP53-NonMutant
7.001600E-01
TP53-Mutant-vs-TP53-NonMutant
7.338200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
